Inventor
William J. Hoekstra
Inventor
Durham, NC, US
Overview
Patents· 79 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes17%
A01NPreservation of bodies of humans or animals or plants or parts thereof11%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07BGeneral methods of organic chemistry3%
Y02ATechnologies for adaptation to climate change3%
C07KPeptides2%
C07CAcyclic or carbocyclic compounds2%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry1%
PatentTitleYear
11,051,514Antifungal compounds202111,040,034Metalloenzyme inhibitor compounds202110,919,874Metalloenzyme inhibitor compounds202110,836,740Antifungal compound process202010,745,378Antifungal compound process202010,676,459Antifungal compounds and processes for making202010,526,312Metalloenzyme inhibitor compounds202010,513,505Antifungal compound process201910,464,921Antifungal compound process201910,464,922Metalloenzyme inhibitor compounds201910,428,025Antifungal compound process201910,421,741Antifungal compound process201910,414,751Antifungal compounds and processes for making201910,407,392Antifungal compound process201910,399,943Antifungal compound process201910,392,365Antifungal compound process201910,370,353Antifungal compounds and processes for making201910,370,354Metalloenzyme inhibitor compounds201910,301,2832-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation201910,221,160Metalloenzyme inhibitor compounds201910,196,375Antifungal compound process201910,173,998Antifungal compound process201910,167,300Metalloenzyme inhibitor compounds as fungicides201910,085,984Metalloenzyme inhibitor compounds201810,077,250Antifungal compound process201810,017,494Antifungal compound process201810,000,465Antifungal compound process20189,988,3652-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and processes for their preparation20189,981,943Antifungal compound process20189,957,252Metalloenzyme inhibitor compounds as fungicides20189,944,664Metalloenzyme inhibitor compounds as fungicides20189,938,255Metalloenzyme inhibitor compounds20189,914,726'2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and processes for their preparation'20189,840,492'Antifungal compounds and processes for making'20179,802,914'Antifungal compound process'20179,688,671'Metalloenzyme inhibitor compounds'20179,663,491'Metalloenzyme inhibitor compounds as fungicides'20179,663,488'Metalloenzyme inhibitor compounds'20179,556,143'Metalloenzyme inhibitor compounds'20179,447,073'Fungicidal compositions'20169,414,596'Metalloenzyme inhibitor compounds'20169,309,273'Metalloenzyme inhibitor compounds'20169,220,265'Metalloenzyme inhibitor compounds'20159,221,791'Metalloenzyme inhibitor compounds'20159,150,527'Metalloenzyme inhibitor compounds'20159,056,855'Metalloenzyme inhibitor compounds'20158,987,315'Metalloenzyme inhibitor compounds'20158,940,735'Metalloenzyme inhibitor compounds'20158,901,121'Metalloenzyme inhibitor compounds'20148,883,797'Metalloenzyme inhibitor compounds'20148,809,378'Metalloenzyme inhibitor compounds'20148,796,001'Metalloenzyme inhibitor compounds'20148,754,227'Metalloenzyme inhibitor compounds'20148,748,461'Metalloenzyme inhibitor compounds'20148,680,270'Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties'20148,669,274'Metalloenzyme inhibitor compounds'20148,623,892'Metalloenzyme inhibitor compounds'20148,389,543'Metalloenzyme inhibitor compounds'20138,236,962'Metalloenzyme inhibitor compounds'20127,718,673'Isonipecotamides for the treatment of integrin-mediated disorders'20107,629,319'Heteroaryl peptidomimetics as thrombin receptor antagonists'20097,618,945'Heteroaryl peptidomimetics as thrombin receptor antagonists'20097,405,303'Substituted quinoline compounds for use as selective estrogen receptor modulator'20087,317,005'Tricyclic benzodiazepines as vasopressin receptor antagonists'20087,183,252'Indole peptidomimetics as thrombin receptor antagonists'20077,081,460'Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders'20066,960,597'Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists'20056,936,604'Bridged bicyclic amino acid-derived [1,4]benzodiazepine vasopressin receptor antagonists'20056,858,577'Indole peptidomimetics as thrombin receptor antagonists'20056,765,004'Indoloazepines as vasopressin receptor antagonists'20046,713,475'Tricyclic benzodiazepines as vasopressin receptor antagonists'20046,365,617'Indole and indazole urea-peptoids as thrombin receptor antagonists'20026,303,625'Triazolopyridines for the treatment of thrombosis disorders'20016,191,145'Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders'20016,156,732'Azole peptidomimetics as thrombin receptor antagonists'20006,069,254'Carboxamide derivatives of piperidine for the treatment of thrombosis disorders'20006,066,651'Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders'20006,017,890'Azole peptidomimetics as thrombin receptor antagonists'20005,770,575'Nipecotic acid derivatives as antithrombotic compounds'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998Based in Bryn Mawr, PA, US· patent location history
2000–2010Patents assigned to ORTHO MCNEIL PHARM INC (14)· patent assignee history
2000–2001Based in Villanova, PA, US· patent location history
2002–2014Based in Chapel Hill, NC, US· patent location history
2008–2021Based in Durham, NC, US· patent location history
2012–2018Patents assigned to VIAMET PHARMACEUTICALS INC (29)· patent assignee history
2012–2015Patents assigned to HOEKSTRA WILLIAM J (14)· patent assignee history
2012–2015Patents assigned to SCHOTZINGER ROBERT J (14)· patent assignee history
2018–2021Patents assigned to MYCOVIA PHARMACEUTICALS INC (20)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VIAMET PHARMACEUTICALS INC | 29 | 2012–2018 |
| MYCOVIA PHARMACEUTICALS INC | 20 | 2018–2021 |
| HOEKSTRA WILLIAM Jself | 14 | 2012–2015 |
| ORTHO MCNEIL PHARM INC | 14 | 2000–2010 |
| SCHOTZINGER ROBERT J | 14 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Durham, NC, US | 59 | 2008–2021 |
| Chapel Hill, NC, US | 13 | 2002–2014 |
| Villanova, Pennsylvania, US | 6 | 2000–2001 |
| Bryn Mawr, Pennsylvania, US | 1 | 1998 |